Vaxcyte EVP, Chief Scientific Officer and COO Jim Wassil reports sale of common shares worth $137,024.083
PCVX•Vaxcyte executive Jim Wassil sold 2,250 common shares worth $137,024.083 on Nov. 2, 2026, and exercised options for 2,250 shares at $5.35 each.
1. Share transactions
Wassil sold 1,907 shares at $60.779 each and 343 shares at $61.57 each on Nov. 2, 2026. After the transactions, his direct holdings totaled 145,435 common shares, according to a Form 4 dated Nov. 4.
